Appointment marks a pivotal step in Lucid’s next phase of growth, strengthening its ability to translate complex science into ...

First-in-class oral therapy mimics the effects of exercise with broad potential as a novel treatment for muscle-sparing ...

OPEN Health today announced the appointment of Tim Perryman as Global Head of Operations, strengthening the company’s ...

OPEN Health today announced the appointment of Cara Priest as Chief People Officer, reinforcing the company’s commitment to ...

OPEN Health today announced the appointment of Peter Black as EVP, Global Client Partner and Transformation Lead.

Sandoz has appointed Armin Metzger as President, Biosimilar Development, Manufacturing & Supply. Metzger will also become a ...

The antibiotics are needed to combat key drug-resistant bacteria causing severe bloodstream and urinary tract infections, ...

BioDuro has appointed Andrew Thomas (top left) and Stevan Djuric (top right) as Scientific Advisors.

Odyssey Therapeutics, a clinical-stage biopharmaceutical company, has appointed H. Martin Seidel to its Scientific Advisory ...

Imfinzi (durvalumab), in combination with standard-of-care FLOT chemotherapy (fluorouracil, leucovorin, oxaliplatin, and ...

L-R: Brian Morrissey, General Manager, Michael Gately, Head of Operations and Declan Hoare, Head of Quality meet with the ...

As AI drives seismic change across the pharmaceutical industry, its adoption is accompanied by uncertainty and risk.